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ABSTRACT
5-hydroxymethylcytosine (5hmC) has been sug-
gested to be involved in various nucleic acid trans-
actions and cellular processes, including transcrip-
tional regulation, demethylation of 5-methylcytosine
and stem cell pluripotency. We have identified an
activity that preferentially catalyzes the cleavage
of double-stranded 5hmC-modified DNA. Using bio-
chemical methods we purified this activity from
mouse liver extracts and demonstrate that the en-
zyme responsible for the cleavage of 5hmC-modified
DNA is Endonuclease G (EndoG). We show that
recombinant EndoG preferentially recognizes and
cleaves a core sequence when one specific cyto-
sine within that core sequence is hydroxymethy-
lated. Additionally, we provide in vivo evidence that
EndoG catalyzes the formation of double-stranded
DNA breaks and that this cleavage is dependent
upon the core sequence, EndoG and 5hmC. Finally,
we demonstrate that the 5hmC modification can
promote conservative recombination in an EndoG-
dependent manner.
INTRODUCTION
The existence of 5-hydroxymethylcytosine (5hmC) in mam-
malian DNA was shown in 1972 (1). At that time the func-
tion of 5hmCwas relegated to the status of a non-mutagenic
DNA lesion (2). The significance of the 5hmCmodification
was realized more than 30 years later, when 5hmCwas iden-
tified in specialized Purkinje neurons (3) and this modifi-
cation was implicated in the oxidative demethylation of 5-
methylcytosine (5meC) (4).
Tet1 was described as the founding member of a class
of iron-dependent dioxygenases that catalyzed the forma-
tion of 5hmC from 5meC (4). Later it was shown that
all three known Tet enzymes––Tet1, Tet2 and Tet3––could
catalyze this reaction (5). Further research demonstrated
the importance of 5hmC and the Tet enzymes in cancer
development when it was shown that deficiencies in Tet2
cause aberrant genomic 5hmC patterns; this led to cer-
tain myeloid cancers (6–8). Other research has shown that
5hmC is present in stem cells (9) and has suggested that
5hmC is necessary for stem cell renewal (10), transcrip-
tional regulation (11–14) and is an intermediate in the ox-
idative demethylation of 5meC. This demethylation is ac-
complished either by using the base excision repair machin-
ery (15,16) or by successive oxidation steps leading to 5-
carboxycytosine (17). 5-carboxycytosine can be removed by
the thymine DNA glycosylase (18,19) or an, as yet, uniden-
tified 5-carboxycytosine decarboxylase (20).
Recent genome-wide mapping of the positions of 5hmC
have demonstrated that 5hmC is present at the highest
amounts in gene bodies and to a lesser extent at the promot-
ers of genes (21–25). The functional significance of the posi-
tioning of 5hmC remains unclear. Early models suggest that
5hmC at gene promoters could alleviate transcriptional re-
pression by 5meC (26); however, this model is not consistent
with several current studies that demonstrate that 5hmC at
gene promoters reduces gene expression (11–13,22). 5hmC
within gene bodies has a limited effect on gene expression
(12) and it has been suggested that 5hmCwithin gene bodies
may be involved in RNA splicing.
Endonuclease G (EndoG) was initially purified from the
mitochondria of bovine heart (27) and calf thymus nuclear
extracts (28). It gained its name for its ability to preferen-
tially cleave guanosine (G)-rich DNA regions (29). Later
it was reported that EndoG localizes primarily to the mi-
tochondria (30); however, more recent reports suggest that
EndoG also resides in the nucleus (31–33). EndoG was
shown to be involved in the removal of RNA primers cre-
ated during mitochondrial DNA replication (30). After this
finding, it was also demonstrated that EndoG could be a nu-
clease involved in the execution of apoptosis (34). However,
two EndoG knockout mice failed to show any apoptotic de-
fects ormtDNA replication errors (35,36). Several recent re-
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ports implicate EndoG in specialized DNA recombination
events (31–33,37).
In this report, we identify and purify an activity in mouse
liver extracts that preferentially cleaves 5hmC-modified
DNA. We show that EndoG is required for this 5hmC
cleavage activity. We characterize a preferred sequence of
EndoG-mediated cleavage and demonstrate that this cleav-
age is greatly increased in the presence of cytosine hydrox-
ymethylation. We show that EndoG is necessary and suffi-
cient for 5hmC-mediated cleavage both in vitro and in vivo.
Finally, we demonstrate that 5hmC-modified DNA under-
goes conservative recombination more frequently than un-




The mouse studies were approved by Folkehelseinstituttet;
and as such comply with Norwegian National and Local
Regulations. Mice were euthanized by cervical dislocation
under isoflurane anesthesia.
Antibodies
The following antibodies were used for this study: -actin
(western blot 1:1000, Enzo Life Science, ADI-905–733),
CoxIV (western blot 1 g/ml, Invitrogen, 459600), EndoG
(western blot 1:200, Santa Cruz Biotechnology, sc-26923),
Histone H3 (western blot 1:250, Diagenode, cs-135–100),
 -H2AX (immunofluorescence 0.2 g/ml, Millipore, 05–
636), 53BP1 (immunoflourescence 1:100, Abcam, ab36823).
Organ nuclear extract preparation
Organs were harvested from euthanized 3-month-old
C57bl/6J or C57bl/6J Endog−/− mice. Endog−/− mice were
a gift from Esther Dupont-Versteegden; their creation was
described previously (36). Organ extracts were prepared as
previously described (3,38). The purity of liver nuclear ex-
tracts (LiNE) was evaluated by western analysis followed by
probing with mitochondrial complex IV, Histone H3 and
EndoG antiserum (Supplementary Figure S1). Wild-type
and EndoG−/− extracts were blotted and probed with actin
antiserum to show equal loading (Supplementary Figure
S2A). Adenosine triphosphate (ATP) hydrolysis assays were
used to demonstrate enzymatically active extracts (Supple-
mentary Figure S2B).
ATP hydrolysis reactions
Reactions (20 l) containing 1.2 g of wild-type or
Endog−/− LiNE, 3 mM  -[32P]-ATP (10 mCi/mmol), 25
mMTris (pH 7.5), 3mMMgCl2, 20mMNaCl and 5mM-
mercaptoethanol were incubated at 37◦C for 120min. Reac-
tions were terminated by the addition of 10 l of a solution
containing 33mMethylenediaminetetraacetic acid (EDTA)
(pH 8.0), 6 mMATP and 6 mMK2PO4. Two microliters of
each reaction was spotted on PEI cellulose F plates (Milli-
pore) and allowed to dry. The plates were resolved in a TLC
chamber containing 1 M formic acid and 0.8 M LiCl. The
plates were dried and placed on a phosphor screen (Molecu-
lar Dynamics) overnight. The phosphor screen was imaged
with a Typhoon Scanner (Molecular Dynamics) and quan-
tified using ImageQuant Software (GE Healthcare).
Stable cell lines
Note that 1.5 × 105 HeLa cells were plated in a 6-well dish
and allowed to attach for 24 h. Cells were then transfected
with 1 g EndoG shRNA (Santa Cruz) or pcDNA3 Tet2
catalytic domain (Tet2 CD) (a generous gift fromYi Zhang,
construction described in previously (5)). After 48 h, cells
were split and selected with 2 g/ml Puromycin for cells
transfected with EndoG shRNA, or the relevant control
empty vector or 200 g/ml Neomycin for cells transfected
with pcDNA3Tet2CD.After selection for 10–14 days 40 in-
dividual colonies were picked and evaluated for expression.
Cells expressing the lowest EndoG and/or the highest Tet2
CD, as determined by quantitative polymerase chain reac-
tion (qPCR), were used for future experiments. The dou-
bly transfected cell lines were created as above except the
HeLa cells expressing the EndoG shRNA or the empty vec-
tor shRNA were seeded and pcDNA3 Tet2 CD was trans-
fected into these cell lines.
siRNA
Note that 15 000 HeLa cells were transfected using Lipo-
fectamine RNAiMax (Invitrogen) with either control (In-
vitrogen cat nr. AM4611), EndoG siRNA 1 (Invitrogen cat
nr. 4390824 id s707) or EndoG siRNA 2 (Invitrogen cat nr.
4390824 id s708) at a concentration of 30 nM. At the appro-
priate time point total RNAwas harvested and reverse tran-
scribed using a High capacity cDNA synthesis kit (Applied
Biosystems). Alternatively, cells were subject to immunoflu-
orescence (described below). EndoG and Tet2 CD-specific
RNAs were quantified using a Taqman probe designed to
detect EndoG or Tet2 CD. Knockdown efficiency was cal-
culated as the specific transcript in the treated sample di-
vided by the RNA present in the control sample multiplied
by 100%.
5hmC quantification
DNA was purified from each HeLa cell line using or-
ganic extraction, followed by an ethanol precipitation. The
amount of 5hmC present in each DNA sample was quan-
tified using a Quest 5hmC detection kit (Zymo Research)
according to the manufacturer’s instructions.
DNA substrates
Note that 2.7 kbp substrates were created by PCR ampli-
fying the derivatives of the pUC19 vector (Sequence and
PCR primers in Supplementary Tables S1 and S2). Sub-
strates containing 5hmC were amplified in the presence of
d5hmCTP (Bioline) instead of dCTP.
The short substrates were created by annealing oligonu-
cleotides (Supplementary Table S2). The annealed oligonu-
cleotides were cloned into pCR2.1-Topo according to the
manufacturer’s instructions. The short substrates were PCR
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amplified using primers that amplify the region of interest
(Supplemental Table S1). Substrates containing all 5meC
were synthesized using d5mCTP (Fermentas) instead of
dCTP and Phusion Polymerase (Finnzymes) instead of Pfu
Turbo Polymerase. Substrates containing 5hmC were am-
plified in the presence of d5hmCTP (Bioline) instead of
dCTP. The in vivo cut and control substrates were created by
PCR amplification of the entire pCR2.1-Topo vector with
the cut or control substrate cloned into the vector.
Recombination substrates were created by PCR amplifi-
cation of Substrate A and Substrate B (Supplementary Ta-
ble S1). Substrates containing 5hmC were amplified in the
presence of d5hmCTP (Bioline) instead of dCTP.
Oligonucleotide annealing reactions (50 l) contain-
ing 200 pmol of each oligonucleotide were annealed by
heating to 95◦C for 5 min and cooled slowly to room
temperature over 3 h. dsOligonucleotides were resolved
on 15% non-denaturing polyacrylamide gel electrophore-
sis (PAGE), identified using ultraviolet shadowing and ex-
tracted.
Substrates were labeled using  -[32P]ATP (20 Ci) and
T4 polynucleotide kinase (NEB) according to the manufac-
turer’s instructions. Unincorporated ATP was removed us-
ing a nucleotide clean kit (Qiagen).
EndoG and dEndoGI cloning and purification
Full-length EndoG was reverse transcribed from Mus mus-
culus liver RNA, PCR amplified and cloned into pET28a
(pET28a-EndoG). pET28a-EndoG/H128A was created
using Quickchange (Strategene) site directed mutagene-
sis. dEndoGI was reverse transcribed from Drosophila
melanogaster total RNA, PCR amplified and cloned into
pET28a. Rossetta(DE3) ((F− ompT hsdSB (RB− mB−)
gal dcm  (DE3 [lacI lacUV5-T7 gene 1 ind1 sam7
nin5]) pLysSRARE (CamR)) harboring pET28a-EndoG,
pET28a-EndoG/H128A, pET28a-dEndoGI were grown in
Studier Autoinducing Media (39) at 37◦C until the culture
reached an A600 of 0.8. The culture was then shifted to 18◦C
for 16 h. The cells were harvested by centrifugation and sus-
pended in 10 ml EndoGwash buffer (25 mMHepes pH 7.9,
500mMNaCl, 5 mM Imidazole and 10% (v/v) glycerol) for
every 500 ml cells grown. All further steps were carried out
at 4◦C unless otherwise stated. The cells were incubated for
60 min with lysozyme added to a final concentration of 200
ng/l. TritionX-100 was added to a final concentration of
0.1% (v/v) and the cells were heated briefly to 20◦C. The
cell lysate was then sonicated three times for 30 s with a
2-min rest on ice between each sonication. The cell lysate
was cleared by centrifugation at 10 000 × g for 30 min.
The supernatant was applied to a 2.5 ml talon resin (BD
Biosciences) and washed with EndoG wash buffer until the
flow-through contained no detectable proteins. EndoG was
eluted from the talon column using EndoG elution buffer
(25 mM Hepes pH 7.9, 500 mM NaCl, 200 mM Imidazole
and 10% (v/v) glycerol). The resulting purified EndoG or
EndoGI was dialyzed against 100 volumes of EndoG stor-
age buffer (250 mM NaCl, 25 mM Hepes pH 7.9, 1 mM
EDTA pH 8.0 and 50% (v/v) glycerol).
Cleavage assays
Reactions (20 l) containing 4.5 ng DNA substrate or
the indicated amount of dsoligonucleotide, 20 mM Hepes
(pH 7.9), 1 mM EDTA pH 8.0, 3 mM MgCl2, 10 mM 2-
mercaptoethanol, 4% (v/v) glycerol, 1% (v/v) TritonX-100,
0.2 ng poly(dIdC) (unless otherwise stated) and a titration
of the nuclear extracts from 25 to 100 ng or the indicated
amount of purified EndoG or EndoG/H128A were incu-
bated at 37◦C for 30 min. Reactions were stopped by the
addition of 4 l stop solution (50 mM Tris (pH 8.0), 2%
(w/v) sodium dodecyl sulphate (SDS), 100 mMEDTA (pH
8.0) and 1 g Proteinase K). The stop solution was allowed
to incubate with the reaction at 42◦C for at least 30 min.
After incubation the entire reaction mixtures were resolved
on a 0.8% or a 1.2% agarose or 15% non-denaturing PAGE.
The agarose gels were incubated with 40% (v/v) methanol,
10% (v/v) acetic acid and 3% (v/v) glycerol for at least 60
min. The gels were then dried and were imaged on a phos-
phor screen.
Kinetic parameters
Cleavage assays were performed as described above with a
decreasing titration of the indicated dsDNA substrate (19,
6.3, 2.1 and 0.70 nM) with 1.3 pmol EndoG. Reaction ve-
locities were plotted against substrate concentration. Km
and Vmax were computed using a Lineweaver–Burk plot.
Kcat values were computed as Vmax divided by the EndoG
concentration. The specificity constant (Kcat/Km) was com-
puted by dividing the Kcat by the Km.
Competition assays
Reactions (20 l) containing 4.5 ng DNA substrate, 40 ng
LiNE, 20 mM HEPES (pH 7.9), 1 mM EDTA (pH 8.0), 3
mMMgCl2, 10 mM 2-mercaptoethanol, 4% (v/v) glycerol,
1% (v/v) Triton X-100 and a titration of poly(dIdC) from
0.1-fold molar excess to a 10-fold molar excess was incu-
bated at 37◦C for 30 min. Reactions were stopped by the
addition of 4 l stop solution (50 mM Tris (pH 8.0), 2%
(w/v) SDS, 100 mM EDTA (pH 8.0) and 1 g Proteinase
K). The stop solutionwas allowed to incubate with the reac-
tion at 42◦C for at least 30 min. After incubation the entire
reaction mixtures were resolved on either a 0.8% or a 1.2%
agarose gel. The agarose gel was incubated with 40% (v/v)
methanol, 10% (v/v) acetic acid and 3% (v/v) glycerol for
at least 60 min. The gels were then dried and were imaged
on a phosphor screen.
Gel shift assays
Reactions (10 l) containing 4.5 ng each short (130 bp) cy-
tosine, fully 5meC and fully 5hmC substrates (5hmC), 20
mM HEPES (pH 7.9), 5 mM EDTA pH 8.0, 10 mM 2-
mercaptolethanol, 4% (v/v) glycerol, 1% (v/v) Triton X-
100, the indicated concentration of EndoG were incubated
on ice (4◦C). After 5 min, 5 l of 75% glycerol was added
to each reaction. Reactions were resolved on 6% Native-
PAGE at 4◦C for 16 h. Gels were incubated with 40% (v/v)
methanol, 10% (v/v) acetic acid and 3% (v/v) glycerol for
at least 60 min. The gels were then dried and were imaged
on a phosphor screen.
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Cleavage activity purification
Mouse LiNE were prepared from 54 mice as described
above. All steps were carried out at 4◦C. Pooled nuclear ex-
tracts were dialyzed twice against 100 volumes of Buffer A
(40 mM KCl, 0.2 mM EDTA (pH 8.0), 20 mM Hepes (pH
7.9) and 20% (v/v) glycerol). The dialyzed fraction was cen-
trifuged at 13 000 × g for 15 min and the soluble fraction
was applied to a 4 ml heparin agarose column equilibrated
with buffer A. The heparin column was eluted with a 40
ml linear gradient from 0.04 to 1.0 M KCl. Fractions were
assayed for 5hmC cleavage activity and relevant fractions
(eluting at 50–120mMKCl) were pooled and dialyzed twice
against 100 volumes of Buffer A. The dialyzed fraction was
applied to 4 × 1 ml HiTrapQ columns (Amersham Bio-
sciences) equilibrated with buffer A. The HiTrapQ column
was eluted with a 40 ml linear gradient from 0.04 to 0.75
M KCl. Fractions were assayed for 5hmC cleavage activ-
ity and relevant fractions (eluting at 50–100 mMKCl) were
pooled and dialyzed twice against 100 volumes of Buffer A.
The dialyzed fraction was applied to 3 × 1 ml HiTrap SP
columns (Amersham Biosciences) equilibrated with buffer
A. The HiTrap SP column was eluted with a 30 ml linear
gradient from 0.04 to 1.0 M KCl. Fractions were assayed
for 5hmC cleavage activity and relevant fractions (eluting at
60–80mMKCl) were pooled and dialyzed twice against 100
volumes of Buffer B (250mMKCl, 0.2mMEDTA (pH8.0),
20 mM Hepes (pH 7.9) and 20% (v/v) glycerol). The pool
was concentrated to 500 l using a centricon MWCO 10
000 (Millipore) and applied to a Superdex 75 column equi-
librated in Buffer B. The Superdex 75 column was eluted
with 35ml buffer B. Fractions containing the highest 5hmC-
specific cleavage activity (between 80 and 100 kDa) were
resolved using 4–16% SDS-PAGE. The entire gel lane was
subjected to nanoLC-ESI-MS/MS analysis.
Protein identification
Protein identification using nanoLC-ESI-MS/MS was per-
formed by Proteome Factory (Proteome Factory AG,
Berlin, Germany). The mass spectrometry (MS) system
consisted of an Agilent 1100 nanoLC system (Agilent,
Waldbronn, Germany), NanoMate 100 (Advion, Ithaca,
USA) and a Finnigan LTQ-FT mass spectrometer (Ther-
moFisher, Bremen, Germany). Proteins were in-gel digested
by trypsin (Promega, Mannheim, Germany) and applied to
nanoLC-ESI-MS/MS. Peptides were trapped and desalted
on an enrichment column (Zorbax SB C18, 0.3 mm × 5
mm, Agilent) for 5 min using 1% acetonitrile/0.5% formic
acid as eluent. The peptides were separated on a Zorbax
300 SB C18, 75 m × 150 mm column (Agilent) using
an acetonitrile/0.1% formic acid gradient from 5% to 40%
acetonitrile over 40 min. MS spectra were automatically
recorded by the mass spectrometer according to manufac-
turer’s instrument settings for nanoLC-ESI-MS/MS analy-
ses. Proteins were identified usingMS/MS ion search of the
Mascot search engine (Matrix Science, London, England)
and nr protein database (National Center for Biotechnol-
ogy Information, Bethesda, USA).
In vivo cleavage assays
HeLa cells were transfected with the appropriate siRNA
as described above. After incubation for 48 h HeLa cells
were transfected using FuGene (Invitrogen) with 500 ng of
the appropriate substrate. After a 20-h incubation the total
RNA and DNA was isolated from the HeLa cells. qPCR
was performed on 5 ng DNA using the cut primer set and
the control region primer set. The fraction cut is represented
as the quantity of the cut primer set as a fraction of the con-
trol primer set.
-H2AX and 53BP1 foci assays
Twenty thousand cells of each stably transfected HeLa
cell line or transiently siRNA knocked down cells were
plated in a single well of a Lab-Tek II 8-well chamber slide
(Thermo Scientific) and allowed to settle overnight at 37◦C
in a humidified 5% CO2 incubator. Cells were washed with
phosphate-buffered saline and fixed with ice cold 100%
(v/v) methanol and placed at −20◦C for 10 min. Cells were
washed once with 300 l Tris buffered saline (TBS). Cells
were permeabilized with 300 ml TBST (TBS and 0.5% (v/v)
TritonX-100) for 10 min at 25◦C. Slides were blocked with
blocking solution (300 l TBS, 0.05% (v/v) Tween20 and
5% (w/v) bovine serum albumin) for 1 h at 25◦C. One hun-
dred microliters  -H2AX antiserum in blocking solution
was added to the slides and incubated at 25◦C for 1 h.
Slides were washed three times in TBST for 10 min. One
hundred microliters of Alexa Fluor 594 goat anti-mouse
immunoglobulin G (IgG; Invitrogen) at a titer of 1:500 in
blocking solution was added to the cells for 1 h at 25◦C.
When relevant one hundred microliters of 53BP1 antiserum
in blocking solution was added to the slides and incubated
at 25◦C for 1 h. Slides were washed three times in TBST for
10 min. One hundred microliters of Alexa Fluor 488 goat
anti-rabbit IgG (Invitrogen) at a titer of 1:500 in blocking
solution was added to the cells for 1 h at 25◦C. Slides were
washed with 300 l TBST for 10 min, 300 l TBST and
5 mg/ml DAPI for 10 min and 300 l TBST for 10 min.
Slides were mounted with Mowiol (Calbiochem) and dried
at 25◦C in the dark for at least 2 h. Slides were visualized
with an Axio Observer.Z1 Axio inverted microscope (Carl
Zeiss) and quantified using AxioVision Software Release
4.8 (Carl Zeiss).  -H2AX foci were counted from 180 to 220
cells of each cell line in duplicate.  -H2AX and 53BP1 foci
were counted in 40–60 cells of EndoG siRNA knockdowns.
Irradiation of HeLa cells
Twenty thousand HeLa cells were plated in each well of a
Lab-Tek II 8-well chamber slide (Thermo Scientific) and al-
lowed to settle overnight at 37◦C in a humidified 5% CO2
incubator. Cells were irradiated in a Gammacell 3000 Elan
(MDS Nordicon) with a dose of either 1 or 3 Gy. Cells
were shifted to a 37◦C humidified 5% CO2 incubator for
30 min. Cells were washed with phosphate-buffered saline
and fixed with ice cold 100% (v/v) methanol and placed at
−20◦C for 10min. Cells were washed once with 300 l TBS.
Cells were permeabilized with 300 ml TBST (TBS and 0.5%
(v/v) TritonX-100) for 10 min at 25◦C. Slides were blocked
with blocking solution (300 l TBS, 0.05% (v/v) Tween20
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and 5% (w/v) bovine serum albumin) for 1 h at 25◦C. One
hundred microliters  -H2AX antiserum and 53BP1 anti-
serum in blocking solution was added to the slides and in-
cubated at 25◦C for 1 h. Slides were washed three times in
TBST for 10 min. One hundred microliters of Alexa Fluor
594 goat anti-mouse IgG (Invitrogen) and Alexa Fluor 488
donkey anti-rabbit IgG, both at a titer of 1:500, in block-
ing solution was added to the cells for 1 h at 25◦C. Slides
were washed with 300 l TBST for 10 min, 300 l TBST
and 5 mg/ml DAPI for 10 min and 300 l TBST for 10
min. Slides were mounted with Mowiol (Calbiochem) and
dried at 25◦C in the dark for at least 2 h. Slides were visu-
alized with an Axio Observer.Z1 Axio inverted microscope
(Carl Zeiss) and quantified using AxioVision Software Re-
lease 4.8 (Carl Zeiss).
Growth curves and viability measurements of stable cell lines
Each cell line was plated in a 6-well dish at a density of 105
cells per well. At the time point indicated cells were har-
vested and mixed with an equivalent volume of 0.4% Try-
pan blue. Cell counts and viability was measured using a
countess cell counter (Invitrogen).
Apoptosis assays
Twenty thousand cells of each stably transfected HeLa cell
line per well were plated in an Lab-Tek II 8-well chamber
slide (Thermo Scientific) and allowed to attach overnight
at 37◦C in a humidified 5% CO2 incubator. The Click-iT
TUNEL Alexa Fluor 594 Imaging Assay Kit (Life Tech-
nologies) was used according to the manufacturer’s instruc-
tions. Slides were mounted with Mowiol (Calbiochem) and
dried at 25◦C in the dark for at least 2 h. Slides were vi-
sualized with an Axio Observer.Z1 Axio inverted micro-
scope (Carl Zeiss) and quantified using AxioVision Soft-
ware Release 4.8 (Carl Zeiss). Data presented are the results
of counting between 200 and 250 cells from each cell line in
duplicate.
Recombination assays
Reactions (50 l) containing 100 ng of Substrate A and 100
ng Substrate B, either unmodified or fully 5hmC-modified,
15.4 g LiNE, 20 mM HEPES (pH 7.9), 1 mM EDTA pH
8.0, 3 mMMgCl2, 10 mMKCl, 10 mM 2-mercaptoethanol,
4% (v/v) glycerol, were incubated for 15 min at 37◦C. Reac-
tions were terminated by the addition of 10 l stop solution
(50 mM Tris (pH 8.0), 2% (w/v) SDS, 100 mM EDTA (pH
8.0) and 1 g Proteinase K) and incubated at 42◦C for at
least 30 min. DNA was purified using a Qiagen PCR clean
kit. Two qPCR reactions were run on each reaction: con-
trol region and recombined region (primers in Supplemen-
tary Table S2) were completed as previously described (40).
The percent recombinant was computed using the formula:
((recombined region quantity)/(control region recovered))
× 100%. The value recorded for the reaction incubated in
the absence of LiNE was subtracted from the result of this
calculation.
Sequencing of recombinant qPCR reactions
qPCR amplification reactions were resolved on 1.4%
agarose gel. The only band present in the gel at 420 bp was
excised and the agarose was removed using a gel extraction
kit (Qiagen). This band was PCR amplified and cloned into
pCR4-Topo (Invitrogen) according to the manufacture’s in-
structions. Twelve colonies from each cloning reaction (48
in total) were grown and the resulting plasmids were puri-
fied using a miniprep kit (Qiagen). Isolated plasmid clones
were sequenced using Sanger sequencing.
Statistical analysis
A two-tailed Student’s t-test was used to evaluate statistical
significance. P-values less than 0.05 were considered statis-
tically different.
RESULTS
Identification of an activity frommammalian nuclear extracts
that produces specific cleavage products from 5hmC-modified
DNA
We were interested in determining the effect that mouse
LiNE would have on 5hmC-modified DNA. With this idea
in mind, we designed two substrates that were PCR prod-
ucts derived from pUC19 (see Supplementary Tables S1
and S2 for substrate and primer sequences; the GC and
G5hmC densities of the substrates, averaged over a 20-bp
window, are shown in Figure 1A). The first substrate con-
tained unmodified cytosines and the other substrate con-
tained 5hmC in place of all the cytosines. Each of these sub-
strates was incubated with increasing concentrations of pu-
rified LiNE (Supplementary Figure S1) and theDNAprod-
ucts were resolved on an agarose gel (Supplementary Fig-
ure S3). Surprisingly, in the lanes that contained the 5hmC-
modified substrate we observed the appearance of several
distinct bands after the incubation with LiNE (Supplemen-
tary Figure S3, lanes 6–8). These distinct bands were not
present in the reactions that contained the unmodified cyto-
sine substrate incubated with LiNE (Supplementary Figure
S3, lanes 2–4).
In addition to the products liberated when the 5hmC-
modified substrate was incubated with LiNE, we noted an
apparent non-specific nuclease activity present in LiNEs
that degraded both cytosine and 5hmC substrates (Supple-
mentary Figure S3, lanes 2 and 6). We titrated increasing
concentrations of poly(dIdC) into the cleavage reactions to
demonstrate that the endonuclease activity observed prefer-
entially cleaved 5hmC-modified DNA (Figure 1B). We ob-
served that as the amount of poly(dIdC) increased, the non-
specific nuclease activity decreased in the cleavage reactions
involving both the cytosine and 5hmC substrates. The spe-
cific cleavage products created by incubating LiNE with the
5hmC-modified substrate appeared to increase with incre-
menting amounts of poly(dIdC) (Figure 1B, lanes 8–10).
This result suggests that an activity from the LiNE was
preferentially catalyzing the formation of sequence-specific
double-stranded DNA breaks provided the DNAwas cyto-
sine hydroxymethylated.
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Figure 1. A component of LiNE preferentially cleaves 5hmC-modified DNA. 4.5 ng (2.6 fmol DNA molecules) of either cytosine or the fully 5hmC-
modified 2.7 kbp substrates (A) were incubated with 25 ng LiNE with an increasing molar excess (0.1- to 10-fold) of poly(dIdC) (B). *, radioactive label;
S, substrate; P, products.
Identification of the enzyme that catalyzes the formation of
specific cleavage products from 5hmC-modified DNA
We endeavored to identify the protein or protein complex
responsible for the cleavage activity observed in Figure 1B.
Nuclear extracts from the livers of 54 mice were prepared
and fractionated according to the scheme shown in Fig-
ure 2A. After each purification step the fractions were as-
sayed for double-stranded 5hmC-modified DNA cleavage
activity (Supplementary Figures S4–S7). Fractions from
each purification step that contained the greatest double-
stranded 5hmC-specific cleavage activity were pooled and
subjected to further fractionation (Figure 2B). During pu-
rification of the cleavage activity we noted a reduced cleav-
age specificity; however, we note that at high enzyme con-
centrations many endonucleases display reduced specificity
(41), indeed at the end of the purification we were able to
recover the specific cleavage products after incubation with
5hmC-modified DNA (Figure 2B). After the final purifica-
tion step, proteins were resolved using SDS-PAGE. The en-
tire gel lane was subjected to nanoLC-ESI-MS/MSanalysis
to identify proteins of interest. The nanoLC-ESI-MS/MS
analysis identified 259 proteins (Supplementary Table S3
and Supplementary Figure S8). Several of these proteins
contained putative nuclease domains; however, EndoG be-
came a primary candidate because EndoG was the only
protein that has been previously demonstrated to function
as an endonuclease (42). Therefore, we tested LiNE from
Endog−/− mice for cleavage activity on both the cytosine
and 5hmC-modified substrates. Supplementary Figure S2A
andB demonstrate that wild-type andEndog−/− LiNE both
contain equivalent amounts of protein, measured by west-
ern blot, and are equally active, asmeasured byATP hydrol-
ysis assays. Interestingly, LiNE lacking EndoG, when incu-
bated with a 5hmC-modified substrate, did not catalyze the
formation of specific cleavage products (Figure 2C). This
result strongly supports the hypothesis that EndoG is nec-
essary for the observed 5hmC cleavage activity.
Recombinant EndoG preferentially cleaves 5hmC-modified
DNA
We expressed and partially purified recombinant mouse
EndoG and a catalytically inactive mutant of EndoG–
EndoG/H128A––from Escherichia coli (Supplementary
Figure S9). The cytosine or the 5hmC-modified sub-
strate was incubated with LiNE, recombinant EndoG or
EndoG/H128A. Intriguingly, we noted that recombinant
EndoG produced the same cleavage pattern as the LiNE
(Figure 2D, lanes 4 and 6 and Supplementary Figure S10).
Furthermore, the catalytically inactive EndoG/H128A was
unable to cleave the cytosine or the 5hmC-modified sub-
strate (Figure 2D, lanes 7 and 8). The production of spe-
cific cleavage products was dependent on EndoG concen-
tration (Figure 2E and Supplementary Figure S10). Ele-
vated EndoG concentrations and long incubation times re-
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Figure 2. Purification and identification of EndoG that preferentially cleaves 5hmC-modified DNA. Purification scheme, using mouse livers as a starting
material, for the endonuclease that preferentially cleaves 5hmC-modified DNA (A). 4.5 ng (2.6 fmol DNA molecules) of either unmodified or 5hmC-
modified DNA substrates were incubated with each successive column pool (B). Full column activity fractions are shown in Supplementary Figures
S4–S7. 4.5 ng (2.6 fmol DNA molecules) of either cytosine or 5hmC-modified substrates were incubated with 50 ng LiNE from wild-type mice or 50 ng
LiNE derived from Endog−/− mice (C). 50 ng LiNE, 6.5 nM Purified EndoG or 6.5 nM Purified EndoG/H128A were incubated with 4.5 ng (2.6 fmol
DNAmolecules) unmodified or 5hmC-modified 2.7 kbp DNA substrates (D). Quantification of the specific cleavage products resulting from a titration of
EndoG and EndoG/H128A (E). S, substrate; P, products.
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sulted in non-specific DNA degradation (data not shown).
We show that recombinant EndoG does not preferentially
shift 5hmC-modified DNA (Supplementary Figure S11).
While we cannot rule out the possibility that proteins cop-
urifying with EndoG can shift DNA, this result indicates
that EndoG recognizes and binds equally well to the DNA
backbone; the catalytic activity is dependent on the recog-
nition of 5hmC-modified DNA. This data, taken together,
strongly suggests that EndoG is responsible for the prefer-
ential cleavage of 5hmC-modified DNA seen in our LiNE
cleavage assays.
EndoG preferentially cleaves 5hmC-modifiedDNAwithin the
core sequence 5′-GGGG5hmCCAG-3′
Next, we attempted to develop a better understanding of the
cleavage specificity of EndoG for 5hmC-modifiedDNA.We
hypothesized that the bands produced from the 5hmCcleav-
age activity observed in Figure 1B were the result of differ-
ently sized bands produced from the cleavage of the 2.7 kbp
substrate. Therefore, we cloned and sequenced the larger,
∼1.3 kbp band. The resulting sequence suggested that the
preferred EndoG cleavage sequence was 5′-GGGGCCAG-
3′/5′-CTGGCCCC-3′. Indeed, mutating all cytosines to
thymines in this core sequence resulted in a substrate that
could not be cleaved in this region by EndoG (data not
shown). Additionally, we were interested in determining if
5meC in the same context would be a substrate for this spe-
cific cleavage activity. Therefore, we created shorter unmod-
ified, fully 5meC-modified (100% of cytosines are 5meC) or
fully 5hmC-modified (100% of cytosines are 5hmC) sub-
strates and performed an EndoG cleavage assay (Supple-
mentary Figure S12; sequences in Supplementary Table S1).
After incubation with LiNE, substrates that were unmodi-
fied or fully cytosinemethylated did not produce the specific
cleavage products that were observed in the fully cytosine
hydroxymethylated substrates (Figure 3A, compare lanes 5,
8 and 11 with lanes 6, 9 and 12). This result suggests that
the DNA sequence 5′-GGGGCCAG-3′/5′-CTGGCCCC-
3′ is preferred by EndoG for cleavage if the cytosines are hy-
droxymethylated and that cytosine methylation in the same
sequence is not preferentially cleaved by EndoG.
We endeavored to determine if a single cytosine within
the 5′-GGGGCCAG-3′/5′-CTGGCCCC-3′ sequence, if
hydroxymethylated, would be sufficient for preferential
cleavage by EndoG. Therefore, we produced six double-
stranded oligonucleotide substrates that contained a
single 5hmC modification at each of the cytosines in the
5′-CTGGC1C2C3C4–3′/5′-GGGGC5C6AG-3′ sequence,
where the superscripted number represents the cytosine
that is cytosine hydroxymethylated, and a negative control
substrate that contained no cytosine hydroxymethylation
(see Figure 3B for schematic). After incubating each
of these substrates with EndoG, we observed that the
presence of 5hmC in either the fifth or the sixth position
is sufficient for recognition and cleavage by EndoG. This
EndoG-mediated cleavage produces two specific products
(P1 and P2) of the expected size if the cleavage occurs at
the 5′-GGGGCCAG-3′/5′-CTGGCCCC-3′ (Figure 3B,
lanes 6 and 7). The substrate that contains a 5hmC at
the fifth position appears to be most efficiently cleaved
Figure 3. The 5hmC-cleavage activity cannot cleave 5meCmodified DNA
and EndoG preferentially cleaves the sequence 5′-GGGG5hmCCAG-3′.
4.5 ng each short (130 bp) cytosine, fully 5meC and fully 5hmC substrates
(5hmC), 32P labeled at both ends, were incubated with a titration of LiNE
ranging from 37.0 to 333 ng (A). dsOligonucleotides (45 bp) that were
singly 5hmC-modified at the indicated position were incubated with pu-
rified 12.5 nM EndoG (B). S, substrate; P, products; P1, product 1; P2,
product 2.
when incubated with EndoG. Indeed, the kinetics of the
EndoG- and 5hmC-mediated cleavage suggest that 5hmC
at position 5 is strongly preferred as compared with an
unmodified substrate (Table 1). Interestingly, when a 5hmC
is added at both positions 1 and 5 the cleavage specificity
returns to that of unmodified DNA. We then evaluated the
cleavage products to determine the type of end produced
by EndoG-mediated cleavage––blunt, 5′ overhang or 3′
overhang. This was accomplished by resolving a portion
of EndoG cleavage reactions 5 and 6 on denaturing PAGE
(Supplementary Figure S13). This resulted in product sizes
that are consistent with a 5′-GGCC overhang.
EndoG catalyzes cleavage at 5′-GGGGCCAG-3′ sequences
in HeLa cells only if the cytosines are hydroxymethylated
We wanted to demonstrate that EndoG could catalyze the
cleavage of substrates containing 5hmC within the core
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Table 1. Kinetic parameters of EndoG for various unmodified and 5hmC modified dsDNA oligonucleotide substrates. Error represents the standard
deviation from the mean in three independent experiments. See Figure 3B for substrate schematics.
Substrate Km (nM) Vmax (nmol * s−1) Kcat (s−1) Kcat/Km (nM−1 s−1)
Cytosine 11.2 ± 2.29 0.53 ± 0.08 409.9 ± 64.55 36.9 ± 3.17
5hmC pos 5 2.95 ± 1.14 1.99 ± 0.95 1539 ± 731.3 566 ± 263
5hmC pos 1 and 5 10.6 ± 1.41 0.52 ± 0.19 399.6 ± 143.3 38.1 ± 13.8
sequence context 5′-GGGGCCAG-3′/5′-CTGGCCCC-3′
in vivo. Therefore, we created two 4.1 kbp substrates
to be transfected into HeLa cells (Figure 4A; sequences
in Supplementary Table S1): one substrate contained
the core EndoG recognition sequence––5′-GGGGCCAG-
3′/5′-CTGGCCCC-3′ (core substrate)––and the other sub-
strate (mutated core substrate) contained a mutated variant
of the core sequence––5′-AAAATTAG-3′/5′-CTAATTTT-
3′––that could not be cleaved efficiently by EndoG in
vitro. These substrates contained two amplicons: amplicon
I stretches across the core EndoG cleavage sequence, or the
mutated variant of this core sequence; amplicon II is lo-
cated outside the EndoG core sequence. These substrates
were transfected into HeLa cells, cellular DNA was recov-
ered and the DNA cleaved in amplicon I was computed as
a function of transfection efficiency (amplicon II). In HeLa
cells, the core substrate containing 5hmC showed signifi-
cantly less signal than the unmodified core substrate at am-
plicon I (P < 0.02), indicating that more cleavage had oc-
curred at the 5hmC-modified substrate (Figure 4B). After
EndoG knockdown with siRNA 1 (Supplementary Figure
S14) the amount of the 5hmC-modified amplicon I from
the core substrate that remains after transfection into HeLa
cells is not statistically different from amount of amplicon
I remaining in the mutated core substrates. We were unable
to detect any reduction in amplicon I when HeLa cells were
transfected with the mutated core substrates, which do not
contain the EndoG recognition sequence. This data sug-
gests that the 5hmC cleavage activity observed in vivo is de-
pendent on EndoG, cytosine hydroxymethylation and the
sequence 5′-GGGGCCAG-3′/5′-CTGGCCCC-3′.
Tet2 catalytic domain overexpression results in the formation
of EndoG-dependent -H2AX and 53BP1 foci
We were interested in determining if the synthesis of 5hmC
would result in an increase in double-stranded breaks in
vivo, and importantly to determine if this postulated in-
crease in DNA breaks was dependent on EndoG. There-
fore, we created four stably transfected HeLa cell lines: a
HeLa cell line containing empty vectors (control), HeLa
cells expressing the Tet2 CD, HeLa cells expressing a sta-
ble shRNA to EndoG and a HeLa cell line overexpressing
both the Tet2 CD and a stable shRNA to EndoG. Tet2 CD
was chosen because it had been previously described as the
most efficient of the Tet enzymes in catalyzing the conver-
sion of 5meC to 5hmC in vivo (5). The relevant gene ex-
pression characteristics of these cell lines are shown in Sup-
plementary Figure S15A. It is well established that histone
H2AX phosphorylated at Serine 139 ( -H2AX) accumu-
lates at double-stranded DNA breaks (43–45). Therefore,
to measure DNAbreaks we analyzed the  -H2AX foci con-
tent in each of these modified HeLa cell lines. The control
cell line showed  -H2AX foci (Supplementary Figure S16A
and B) levels similar to previous reports (46,47). Irradiated
HeLa cells also showed  -H2AX and 53BP1 foci that were
similar to already published data (48) (Supplementary Fig-
ure S17). The cell line overexpressing the Tet2 CD displays
a dramatic increase in the number of cells with  -H2AX
foci and the number of foci per cell (Supplementary Figure
S16A and B). Indicating that these foci are bona fide double-
stranded DNA breaks, in an independent experiment these
 -H2AX foci co-localize with 53BP1 foci (Figure 4C andD,
cell properties shown in Supplementary Figure S18A–C).
Interestingly, the number of cells with  -H2AX foci and the
number of foci per cell returned to the control level when the
cells are additionally deficient for EndoG (Figure 4C and
D and Supplementary Figure S16A and B). These modified
stable cell lines grew at similar rates (Supplementary Figure
S15B) and similar doubling times (Supplementary Figure
S15C), with the Tet2 CD overexpressing HeLa cell grow-
ing slightly more slowly and therefore have the longest dou-
bling time. The stable cell lines had similar levels of apop-
totic cells (Supplementary Figure S19A and B) and the vi-
ability of each of the cell lines was consistently above 95%
(data not shown), indicating that these EndoG- and 5hmC-
dependent DNA breaks do not kill the cells but are repaired
at the expense of doubling time. These results, taken to-
gether, suggest that an increase in 5hmC in vivo results in ds-
DNA breaks that are formed in an EndoG-dependent man-
ner.
EndoG promotes conservative recombination
We observed that the in vivo and in vitro cleavage of 5hmC-
modified DNA catalyzed by EndoG resulted in the forma-
tion of double-stranded DNA breaks. We speculated that
these double-stranded DNA breaks would be processed
by recombination. We tested this hypothesis by modifying
a previously described recombination assay (40). Briefly,
two recombination substrates were created. These two sub-
strates are identical, except that Substrate A lacks the 3′
region of a well-defined amplicon and Substrate B lacks
the 5′ region of this same amplicon (see Figure 5A for
Schematic; Supplementary Table S1 for sequences). The
substrates when combined in a qPCR reaction will not pro-
duce a product; however, if recombination occurs a qPCR
product will be produced (40). We modified this assay such
that the substrates were either unmodified or each substrate
had every cytosine replaced with 5hmC (100% of cytosines
were 5hmC).We incubated substrateA and substrate Bwith
LiNE and in the presence or absence of a specific inhibitor
of EndoG (dEndoGI) from Drosophila melanogaster. In-
hibition of EndoG-mediated cleavage activity is shown in
Supplementary Figure S20 and as previously described (49).
UnmodifiedDNA substrates incubated with LiNE produce
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Figure 4. EndoG both cleaves cytosine hydroxymethylated DNA within the sequence context 5′-GGGGCCAG-3′ and promotes the formation of  -
H2AX foci in vivo. Schematic (not to scale) of the substrate design for the assay, each 4.1 kbp substrate contained either cytosine or 5hmC in place of all
the cytosines. The core substrate contains the EndoG recognition sequence while the core mutated substrate has the EndoG recognition sequence mutated
(A). 0.5 g of each of the four DNA substrates was transfected into HeLa cells that were treated with a control or EndoG siRNA 1. The total DNA was
recovered 20 h after transfection. Bars on the graph represent the total amount of the core EndoG recognition region remaining (amplicon I) as a fraction
of DNA transfected (amplicon II) quantified by qPCR (B). Data are presented as the mean± standard deviation, n= 7; statistical significance was assigned
using a two-tailed Student’s t-test. Representative images of  -H2AX foci and 53BP1 foci observed in HeLa cells stably transfected with either a control
plasmid or a plasmid that overexpresses the Tet2 CD. Two different siRNAs targeting EndoG were transfected into both the control and the Tet2 CD cell
line and incubated for 48 h (C).  -H2AX foci were counted and grouped according to the number of foci per cell in each of the six combinations of cell
lines evaluated (D).
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Figure 5. EndoG promotes conservative recombination when the DNA is 5hmC-modified. Substrate A lacks the 3′ region of an amplicon containing the
EndoG recognition sequence (blue primers) and Substrate B lacks the 5′ region of this same amplicon. If recombination occurs the complete amplicon
is restored resulting in a quantifiable product. Recombination is quantified as the recombination amplicon quantity (blue primers) as a percent of the
total DNA quantity recovered (orange amplicon). Substrates A and B were either unmodified or 5hmC-modified at every cytosine residues (A). 100 ng
of Substrate A and 100 ng of Substrate B were incubated with 15.3 g LiNE or g LiNE and 3.2 nM of a specific inhibitor of EndoG (EndoGI) from
Drosophila melanogaster as described in the ‘Materials and Methods’ section (B). Data are presented as the mean ± standard deviation, n = 3; statistical
significance was assigned using a two-tailed Student’s t-test. Recombinant amplicons from the recombination assays in panel B were cloned and sequenced,
representative sequences are shown aligned to the expected sequence for a conservative recombinant molecule (top sequence), the relevant sequence of
substrate A (sequence second from top) and the relevant sequence of substrate B (sequence third from top) (C). Full sequences are shown in Supplementary
Figure S21. Model for the initiation of recombination at 5′-GGGGCCAG-3′ sequences mediated by EndoG and cytosine hydroxymethylation (D).
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a low level of recombinant molecules as a percentage of to-
tal DNA (Figure 5B). In contrast, 5hmC-modified DNA
substrates incubated with LiNE produced 4-fold more re-
combinant molecules under the same conditions, a statis-
tically significant increase (P < 0.05) over the unmodified
DNA. Both unmodified and 5hmC-modified DNA incu-
bated with LiNE and dEndoGI result in the formation of
a level of recombinant molecules that is not statistically dif-
ferent from the cytosine substrates incubated with LiNE
alone. This result shows that (i) the 5hmC-modified DNA
is more prone to recombination under the conditions eval-
uated and (ii) this increase in recombination is dependent
on EndoG. Finally, we were interested in determining if the
recombinant molecules formed from this assay were conser-
vative recombinant molecules or if these molecules were the
result of non-conservative recombination. To address this
question we cloned and sequenced each of the qPCR ampli-
cons from the recombination assay performed in Figure 5B.
Twelve replicates from each recombination reaction were
cloned and sequenced, representative sequences are shown
in Figure 5C and in Supplementary Figure S21. In all cases,
we observed that the sequence of all 12 replicates result-
ing recombinant molecules were identical to the expected
sequence for a conservative recombinant molecule. These
results, taken together, suggest that the LiNE supports con-
servative recombination and EndoG promotes this type of
recombination if the DNA is 5hmC-modified.
DISCUSSION
Several studies have implicated cytosine hyper-methylation
as a driving force for the initiation of endogenous double-
stranded breaks (50,51). Interestingly, the techniques used
to identify cytosine methylation in these reports––bisulfite
sequencing––cannot distinguish between cytosine methy-
lation and cytosine hydroxymethylation (52). Therefore, it
is plausible that the endogenous double-stranded breaks
correlating with hyper-methylation are to some extent
endogenous double-stranded breaks induced by hyper-
hydroxymethylation. The presence of an endonuclease that
preferentially cleaves 5hmC-modified DNA provides a ra-
tionale for the increased amount of double-stranded breaks
with increasing cytosine methylation or hydroxymethyla-
tion seen previously (32).
When the Tet2 CD is overexpressed in HeLa cells we ob-
served a significant increase in the number of  -H2AX pos-
itive cells and the quantity of  -H2AX foci per cell, signi-
fying an increase in the number of dsDNA breaks. Impor-
tantly, the quantity of  -H2AX foci returns to near control
levels when EndoG is knocked down. The Tet2 CD over-
expressing HeLa cell line shows a reduction in growth rate,
which was overcome by the additional knockdown of En-
doG. This slowed growth rate may be a response to the sig-
nificant increase in dsDNA breaks. We suggest these breaks
must be repaired as apoptosis is not increased and cell via-
bility is not reduced.
Our results suggest that the 5′-GGGG5hmCCAG-3′ se-
quence is preferentially cleaved by EndoG. Although we
show that the 5′-GGGG5hmCCAG-3′ sequence can be
cleaved by EndoG both in vitro and in vivo, we cannot rule
out the possibility that EndoG can catalyze the cleavage
of other 5hmC-modified sequences. The characterization
of all the EndoG cleavage sequences will certainly be of
importance in future studies given that this modification
and EndoG appears to initiate recombination. Addition-
ally, this hydroxymethylated cytosine is not in a CpG con-
text; however, we note that this 5hmC at this position is
within the CHH (H = A, C or T) sequence context, which
is a known target of cytosine methylation (21,53). The cy-
tosine in this sequence context is likely to be hydroxymethy-
lated at some developmental stage in vivo and is, therefore, a
biologically relevant sequence context. Interestingly, the po-
sitioning and number of 5hmC modifications within the 5′-
GGGGCCAG-3′ sequence context appear to be important
for cleavage by EndoG; substrates modified at the 5 posi-
tion are cleaved over 15 timesmore specifically than unmod-
ified substrates, while substrates modified at positions 1 and
5 are cleaved similar to cytosine alone. Our recombination
assay substrates shown in Figure 5A contain a fully 5hmC-
modified 5′-GGGGCCAG-3′ sequence outside the recom-
bination amplicon. Therefore, the recombination observed
within this region is likely the result of (i) cleavage mediated
by EndoG at an alternative sequence or (ii) cleavage cat-
alyzed by EndoG at the 5′-GGGGCCAG-3′ sequence out-
side the recombination amplicon followed by branchmigra-
tion into and across the recombination amplicon resulting
in the conservative recombination products observed.
We (11,12) and others (13,22) have envisaged a role for
5hmC in transcriptional regulation. Others have demon-
strated that 5hmC has a role in stem cell pluripotency (54)
and in the oxidative demethylation of 5meC (15–17). We do
not believe that these studies conflict with the presence of
an endonuclease that preferentially cleaves 5hmC-modified
DNA. Indeed, cytosine methylation has been demonstrated
to have several cellular functions, likewise cytosine hydrox-
ymethylation potentially has multiple functions, including
the initiation of recombination.
Previous reports (28,32,34) demonstrate that EndoG cre-
ates double-stranded breaks at CG-rich regions; however,
cytosine hydroxymethylation has not been implicated as
a requirement for this cleavage. While we see EndoG-
mediated cleavage at CG-rich regions, EndoG cleaves
5hmC-modified DNA much more efficiently. EndoG re-
sides primarily in the mitochondrial inner membrane space
(30) and in the nucleus at a lower concentration (37). Im-
portantly, the LiNE used for this study were free of any de-
tectable mitochondrial contaminants (Supplementary Fig-
ure S1). EndoG is thought to induce apoptosis in a caspase-
independentmanner (34,55–56). It has also been shown that
EndoG can generate primers necessary for mitochondrial
DNA replication (57). Nevertheless, an Endog-deficient
(Endog−/−) mouse did not show apoptotic defects and did
not show any deficiencies consistent with ineffective or in-
efficient mitochondrial DNA replication (35,36). The ab-
sence of these defects in theEndog−/- mice suggests an alter-
native role for EndoG in nucleic acid metabolism. Indeed,
several studies have shown that EndoG is necessary for
the initiation of recombination by the creation of double-
stranded breaks (31,32). Interestingly, in addition to initi-
ating homologous recombination, EndoG appears to initi-
ate class switch recombination in specialized immune cells
(37). A more recent report indicates that nuclear EndoG
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initiates recombination at the MLL breakpoint (33). Taken
together, these reports and the data in our study, showing
that EndoG prefers to cleave 5hmC-modified DNA and
can promote recombination, strongly suggest that EndoG
can initiate recombination at hydroxymethylated cytosine
residues. Furthermore, a recent report demonstrates that
5hmC is located at recombinational hotspots, suggesting a
role for 5hmC-modified DNA in recombination (23). Sev-
eral reports also suggest that regions of high GC content
are recombinational hotspots (25,58). Therefore, we suggest
that EndoG may be responsible for the initiation of an un-
characterized mode of recombination (Figure 5D). In this
model EndoG would preferentially initiate recombination
by creating double-stranded breaks at specific DNA sites
that are cytosine hydroxymethylated. The 5hmC-specific en-
donuclease activity catalyzed by EndoG is likely to have at
least two levels of regulation preventing unintended double-
stranded breaks within cells. The first level of EndoG reg-
ulation would be accomplished by regulating the cytosine
hydroxymethylation status of the sequence to be cleaved,
regulated by the Tet1–3 enzymes. The second level of regu-
lation, by a protein or protein complex or by exclusion from
the nucleus, would directly modulate the ability of EndoG
to access 5hmC-modified DNA.
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Supplementary Data are available at NAR Online.
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